下垂体腺酸环酶激活多 (PACAP) 和突然婴儿死亡综合征:一个潜在的研究模型
Dénes Tóth1, Gábor Simon1, Dóra Reglődi2
1Department of Forensic Medicine, University of Pécs Medical School, Szigeti út 12, H-7624 Pécs, Hungary.
International journal of molecular sciences
|October 28, 2023
概括
突然婴儿死亡综合征 (SIDS) 的机制尚不清楚. 研究表明, pituitary adenylate cyclase-activating polypeptide (PACAP) 缺乏可能是SIDS的一个关键因素,提供了一个新的研究模式.
科学领域:
- 神经科学是一个神经科学.
- 儿科 儿科 儿科
- 遗传学 是一个遗传学.
背景情况:
- 突然婴儿死亡综合征 (SIDS) 是新生儿后婴儿死亡的主要原因,原因不明.
- 三重风险模型表明,SIDS的结果来自内在的脆弱性,外部触发因素和关键的发育窗口.
- 目前的体内模型不能完全复制人类SIDS的复杂性.
研究的目的:
- 审查和综合关于质腺酸环酶激活多 (PACAP) 与SIDS相关的研究.
- 探索PACAP缺陷作为导致SIDS病原的因素的潜在作用.
- 建议PACAP作为SIDS研究的一个有希望的目标.
主要方法:
- 关于PACAP和PAC1受体 (PAC1R) 研究的综合文献综述.
- 关于PACAP/PAC1R缺失和新生儿死亡率的早期动物研究分析.
- 审查最近的人类遗传研究涉及PACAP和PAC1R在SIDS.
主要成果:
- 早期的动物研究表明,PACAP或PAC1R的缺失与在人类SIDS敏感期内新生儿死亡率的增加有关.
- 最近的人类研究表明,PACAP和PAC1R基因可能有助于SIDS的发展.
- PACAP已知的生理作用包括代谢,热,心血管,呼吸,压力,睡眠和免疫调节.
结论:
- 缺少PACAP可能与SIDS的发病因子有联系.
- PACAP及其受体PAC1R被认为是SIDS的可能贡献者.
- 对PACAP缺陷的进一步调查可以为SIDS研究提供一个有价值的模型.
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Global Regulatory Systems
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...


